2 results about "Orlistat" patented technology

Described are pharmaceutical compositions comprising bupropion, metformin, orlistat, and at least one pharmaceutically acceptable carrier or excipient. Another aspect of the present invention relates to a method of treating a patient suffering from obesity or needing to lose weight, comprising the step of co-administering to said patient a therapeutically effective amount of bupropion, metformin, and orlistat. In certain embodiments, an aforementioned method is practiced in conjunction or tandem with a medical procedure or the use of a medical device or both.

The invention belongs to the field of medicine, and in particular, relates to a pharmaceutical composition containing glucosamine and having a weight reducing function. According to the pharmaceutical composition containing glucosamine and having the weight reducing function, tests find out that glucosamine can significantly increase the orlistat dissolution degree, and greatly improves the orlistat bioavailability. At the same time, the pharmaceutical composition containing glucosamine and having the weight reducing function has a significant weight reducing effect on obesity sensitive type rats; after drug discontinuance, a weight rebound phenomenon does not appear, moreover, diarrhea or loose stools or other side effects do not appear during drug taking, and the pharmaceutical composition is a healthy weight reducing drug having a significant weight reducing effect.